AllianceBernstein
KRON

AllianceBernstein’s Kronos Bio KRON Stock Holding History

AllianceBernstein’s Portfolio KRON Stock Details KRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-52,100
Closed -$76.1K – 3208
2023
Q1 		$76.1K Hold
52,100
– – ﹤0.01% 3053
2022
Q4 		$84.4K Buy
52,100
+3,400
+7% +$7.83K ﹤0.01% 3128
2022
Q3 		$163K Buy
48,700
+2,400
+5% +$10.8K ﹤0.01% 3058
2022
Q2 		$169K Buy
46,300
+6,900
+18% +$31.3K ﹤0.01% 3057
2022
Q1 		$285K Buy
39,400
+100
+0.3% +$853 ﹤0.01% 2892
2021
Q4 		$534K Hold
39,300
– – ﹤0.01% 2714
2021
Q3 		$824K Hold
39,300
– – ﹤0.01% 2572
2021
Q2 		$941K Buy
+39,300
New +$995K ﹤0.01% 2557

Other funds holding KRON

OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PCIG
Partners Capital Investment Group Boston, Massachusetts $2.65B AUM 16.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein's KRON Position: Q2 2023 in Review

AllianceBernstein sold out of Kronos Bio (KRON) in Q2 2023, closing a stake of 52,100 shares — an estimated $76.1K sold.

AllianceBernstein first reported a position in KRON in Q2 2021 and held it in 8 quarters. The position peaked at $941K in Q2 2021. 80 funds tracked by Wall St. Rank hold KRON as of Q2 2023.

  • AllianceBernstein reported no remaining Kronos Bio position as of Q2 2023 after selling out during the quarter.
  • AllianceBernstein sold 52,100 Kronos Bio shares in Q2 2023, an estimated $76.1K.
  • AllianceBernstein first reported a position in Kronos Bio in Q2 2021 and held it in 8 quarters.
  • AllianceBernstein's Kronos Bio position peaked at $941K in Q2 2021.
  • 80 funds tracked by Wall St. Rank held Kronos Bio as of Q2 2023.

Based on AllianceBernstein's 13F filing for Q2 2023, filed 15 Aug 2023.